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1. INTRODUCTION {#acel13127-sec-0001}
===============

The progression of aging is accompanied by a gradual decline of physiological and molecular processes needed to maintain the body\'s homeostasis (López‐Otín, Blasco, Partridge, Serrano, & Kroemer, [2013](#acel13127-bib-0036){ref-type="ref"}). Aging induces a well‐described set of changes in the immune system, which are collectively referred to as immunosenescence (Gruver, Hudson, & Sempowski, [2007](#acel13127-bib-0019){ref-type="ref"}). The weakened response to pathogenic agents and immunization is the most compelling feature of declining immune function (Giefing‐Kröll, Berger, Lepperdinger, & Grubeck‐Loebenstein, [2015](#acel13127-bib-0017){ref-type="ref"}). Another typical feature of aging is a state of chronic, low‐grade inflammation, also known as inflamm‐aging, which is characterized by elevated levels of proinflammatory cytokines (Franceschi et al., [2000](#acel13127-bib-0015){ref-type="ref"}; Sansoni et al., [2008](#acel13127-bib-0050){ref-type="ref"}). Considerable attention has been devoted to understanding the age‐related changes in the adaptive immune compartment, particularly in T cells (Goronzy, Hu, Kim, Jadhav, & Weyand, [2018](#acel13127-bib-0018){ref-type="ref"}; Johnson et al., [2017](#acel13127-bib-0029){ref-type="ref"}; Tserel et al., [2015](#acel13127-bib-0056){ref-type="ref"}; Ucar et al., [2017](#acel13127-bib-0057){ref-type="ref"}). However, many features of inflamm‐aging refer to a dysregulation of the innate immune system, which provides the first line of defense against invading pathogens and mediates signals to regulate the adaptive immune response. A central role in these processes has been attributed to the multifunctional monocyte cell population (Albright et al., [2016](#acel13127-bib-0001){ref-type="ref"}).

Human monocytes constitute approximately 10% of all peripheral blood leukocytes (Guilliams, Mildner, & Yona, [2018](#acel13127-bib-0020){ref-type="ref"}). The phenotyping by cell surface markers CD14 and CD16 has enabled to distinguish three main monocyte subpopulations: the classical CD14^+^CD16^−^ that represent up to 95% of monocytes, intermediate CD14^+^CD16^+^, and nonclassical CD14^−^CD16^+^ cells (Bassler, Schulte‐Schrepping, Warnat‐Herresthal, Aschenbrenner, & Schultze, [2019](#acel13127-bib-0004){ref-type="ref"}; Passlick, Flieger, & Ziegler‐Heitbrock, [1989](#acel13127-bib-0042){ref-type="ref"}) while single‐cell transcriptomics and mass cytometry has enabled even further subtyping of these immune cells (Hamers et al., [2019](#acel13127-bib-0021){ref-type="ref"}; Villani et al., [2017](#acel13127-bib-0060){ref-type="ref"}). Monocytes are important in phagocytosis, antigen presentation, inflammatory processes, and tissue repair and influence many age‐related health conditions, including atherosclerosis, inflammatory diseases, and Alzheimer\'s disease (Bassler et al., [2019](#acel13127-bib-0004){ref-type="ref"}; Jakubzick, Randolph, & Henson, [2017](#acel13127-bib-0027){ref-type="ref"}; Tabas & Lichtman, [2017](#acel13127-bib-0053){ref-type="ref"}; Wynn & Vannella, [2016](#acel13127-bib-0065){ref-type="ref"}; Zigmond et al., [2012](#acel13127-bib-0071){ref-type="ref"}). Recently, efforts have been made to elucidate the role of monocytes in aging by applying genome‐wide approaches that measure gene expression and DNA methylation (Liu, Ding, Reynolds, Lohman, & Register, [2013](#acel13127-bib-0033){ref-type="ref"}; Metcalf et al., [2017](#acel13127-bib-0039){ref-type="ref"}; Reynolds et al., [2014](#acel13127-bib-0046){ref-type="ref"}, [2015](#acel13127-bib-0047){ref-type="ref"}). These findings highlight a crucial role of monocytes in immunosenescence and suggest that aging affects the monocytic gene expression program associated with protein synthesis and cellular energy homeostasis (Metcalf et al., [2017](#acel13127-bib-0039){ref-type="ref"}; Reynolds et al., [2014](#acel13127-bib-0046){ref-type="ref"}, [2015](#acel13127-bib-0047){ref-type="ref"}). With age, monocytes are recruited to atherosclerotic lesions by using the CX3CR1 chemokine receptor (Tacke et al., [2007](#acel13127-bib-0054){ref-type="ref"}), which has higher expression in older persons (Metcalf et al., [2017](#acel13127-bib-0039){ref-type="ref"}). Furthermore, the transcription co‐activator ARID5B, which promotes the expression of proinflammatory markers, is upregulated in monocytes from old individuals (Liu et al., [2017](#acel13127-bib-0034){ref-type="ref"}). The age‐related mitochondrial dysregulation observed in many other cell types manifests itself in monocytes as a decrease in the maximal respiratory capacity (Pence & Yarbro, [2018](#acel13127-bib-0043){ref-type="ref"}).

Aging also influences the cytokine profile of monocytes after stimulation with TLR ligands. Specifically, studies in monocytes from elderly individuals have shown a weaker IFN‐β and IL‐1β response to influenza A virus and LPS treatment, respectively (Pillai et al., [2016](#acel13127-bib-0045){ref-type="ref"}; Sadeghi, Schnelle, Thoma, Nishanian, & Fahey, [1999](#acel13127-bib-0049){ref-type="ref"}). Additionally, Metcalf et al., ([2017](#acel13127-bib-0039){ref-type="ref"}) reported that 5'pppRNA treatment resulted in lower induction of IFN‐α and CCL8, while LPS stimulation triggered a weaker production of IFN‐γ and IL‐1β in monocytes extracted from older donors. Moreover, low responsiveness to cytokines is characteristic of monocytes and other immune cells of aged individuals (Shen‐Orr et al., [2016](#acel13127-bib-0052){ref-type="ref"}).

In this study, we used genome‐wide gene expression and DNA methylation profiling of CD14^+^ monocytes extracted from individuals older than 65 years and compared the results to those found in CD14^+^ monocytes collected from healthy adults aged 23--41. We found that aging affects the expression of genes involved in protein synthesis, mitochondrial energy metabolism, and cellular motility. In addition, we found decreased expression of phospholipase A2 group 4B (*PLA2G4B*) and arachidonate 15‐lipoxygenase, type B (*ALOX15B*) mRNA, two enzymes that belong to the arachidonic acid metabolic pathway. Furthermore, we used a targeted metabolomics approach to investigate the aging‐related changes in metabolite content in monocytes and discovered increased concentrations of several phosphatidylcholine (PC) species. Similarly, we found that the inhibition of phospholipase A2 activity in a monocytic cell line results in elevated levels of PCs. Based on these large‐scale screens, we performed a comprehensive analysis of key markers of cellular physiology to compare the steady‐state and LPS‐stimulated monocytes extracted from old and young individuals and discovered important age‐related disturbances in energy metabolism.

2. RESULTS {#acel13127-sec-0002}
==========

2.1. Monocytes from older individuals display gene expression hallmarks of aging and reveal an impact on arachidonic acid metabolism {#acel13127-sec-0003}
------------------------------------------------------------------------------------------------------------------------------------

We performed genome‐wide mRNA expression profiling to identify the genes that are differentially expressed in CD14^+^ monocytes from younger adults (average age 35.7 years, standard deviation 4.9) and older individuals (average age 71.6 years, standard deviation 3.1) (Table [S1](#acel13127-sup-0002){ref-type="supplementary-material"}). We found that a large fraction of genes encoding ribosomal proteins (\~50 out of 80) had a moderate decline of approximately 10%--20% in the CD14^+^ cells extracted from the older subjects (Figure [1a](#acel13127-fig-0001){ref-type="fig"} and Table [S2](#acel13127-sup-0003){ref-type="supplementary-material"}). The second largest group of genes that displayed reduced expression in monocytes of older individuals was associated with mitochondrial functions, including oxidative phosphorylation and transport through the mitochondrial membranes (Figure [1a](#acel13127-fig-0001){ref-type="fig"} and Table [S2](#acel13127-sup-0003){ref-type="supplementary-material"} & [S3](#acel13127-sup-0004){ref-type="supplementary-material"}). We found that the largest group of genes, the expression of which was increased with age, was associated with cell motility and migration (Figure [1a](#acel13127-fig-0001){ref-type="fig"} and Table [S2](#acel13127-sup-0003){ref-type="supplementary-material"} & [S3](#acel13127-sup-0004){ref-type="supplementary-material"}). The three out of five top upregulated genes---epidermal growth factor receptor pathway substrate 8 (*EPS8*), formyl peptide receptor 1 (*FPR2*), and C‐X3‐C motif chemokine receptor 1 (*CX3CR1*)---were associated with cell movement, chemotaxis, and inflammatory processes (Aoki et al., [2016](#acel13127-bib-0002){ref-type="ref"}; Imai et al., [1997](#acel13127-bib-0024){ref-type="ref"}; Tiffany et al., [2001](#acel13127-bib-0055){ref-type="ref"}) (Figure [1b](#acel13127-fig-0001){ref-type="fig"}). In particular, CX3CR1, which binds fractalkine thereby promoting monocyte migration and cell adhesion, has been shown to direct monocytes to atherosclerotic lesions in blood vessels (Tacke et al., [2007](#acel13127-bib-0054){ref-type="ref"}). Our list of upregulated genes also includes the transcription factor AT‐rich interaction domain 5B (ARID5B), which has been shown to activate adipogenic gene expression and promote the expression on atherogenic markers in monocytes (Liu et al., [2017](#acel13127-bib-0034){ref-type="ref"}; Whitson, Tsark, Huang, & Itakura, [2003](#acel13127-bib-0062){ref-type="ref"}; Yamakawa, Whitson, Li, & Itakura, [2008](#acel13127-bib-0067){ref-type="ref"}) (Table [S2](#acel13127-sup-0003){ref-type="supplementary-material"}). Another highly upregulated gene was pyruvate dehydrogenase kinase 4 (*PDK4*), which inhibits the pyruvate dehydrogenase complex, thereby shifting glucose metabolism from oxidative phosphorylation to lactate production (Park & Jeoung, [2016](#acel13127-bib-0041){ref-type="ref"}) (Figure [1b](#acel13127-fig-0001){ref-type="fig"}).

![Expression analysis of monocytes extracted from young adults and old individuals. (a) Heatmap of age‐related differentially expressed genes that encode ribosomal or mitochondrial proteins or affect cell motility. (b) Gene expression comparison of top 5 downregulated (first column) and top 5 upregulated (second column) genes in monocytes between age groups. (c) The relative expression of genes *PLA2G4B* and *ALOX15B* in monocytes extracted from young adults (20 samples) and old persons (21 samples). Monocytes were isolated from fresh samples and the cell pellets stored frozen until RNA extraction. Asterisks show FDR‐adjusted *p*‐value ranges: *p* \< .1; \**p* \< .05; \*\**p* \< .01; \*\*\**p* \< .001 (Wald test in (b) and ANOVA in (c))](ACEL-19-e13127-g001){#acel13127-fig-0001}

Interestingly, two of the top downregulated genes---phospholipase A2 group IV family (*PLA2G4B*) and arachidonate 15‐lipoxygenase type B (*ALOX15B*)---encode enzymes that belong to the arachidonic acid metabolism pathway (KEGG: ko00590) (Figure [1b](#acel13127-fig-0001){ref-type="fig"},[c](#acel13127-fig-0001){ref-type="fig"}). The *PLA2G4B* encoded cPLA~2~‐β enzyme converts phosphatidylcholines (PCs) to arachidonic acid, which is a known precursor of many important pro‐ and anti‐inflammatory mediators. The ALOX15B protein can catalyze the formation of 15(S)‐ and 8(S)‐hydroxyeicosatetraenoic (HETE) acids, which are able to trigger PPAR‐γ‐mediating anti‐inflammatory responses, or can be metabolized further to lipoxins that are endogenous anti‐inflammatory and pro‐resolving molecules counteracting chronic inflammation (Chandrasekharan & Sharma‐Walia, [2015](#acel13127-bib-0009){ref-type="ref"}; Chawla, [2010](#acel13127-bib-0010){ref-type="ref"}; Ivanova et al., [2015](#acel13127-bib-0025){ref-type="ref"}). Other top downregulated genes included the major histocompatibility complex class I pseudogene J (*HLA‐J*), the uncharacterized long noncoding RNA gene RP11‐42I10.1, and the G protein‐coupled receptor 27 (*GPR27*) (Figure [1b](#acel13127-fig-0001){ref-type="fig"}). Thus, our analysis detected major groups of genes that are associated with the hallmarks of aging and highlighted the age‐related downregulation of two enzymes in the arachidonic acid metabolism pathway, suggesting impaired regulation of chronic inflammation.

2.2. DNA methylation changes in monocytes of old subjects occur at known aging marker sites {#acel13127-sec-0004}
-------------------------------------------------------------------------------------------

We analyzed genome‐wide DNA methylation patterns with the Illumina Infinium 450 K BeadChip technology and compared samples from young adults (average age 34.2 years, standard deviation 4.7) to older individuals (average age 71.7 years, standard deviation 3.3). Altogether, we detected 2,967 CpG sites that displayed differential methylation between age groups (Table [S4](#acel13127-sup-0005){ref-type="supplementary-material"}). We found that the top hypermethylated sites in samples from old individuals include CpGs at *ELOVL2* and *FHL2* gene loci, which have been shown to strongly correlate with age (Garagnani et al., [2012](#acel13127-bib-0016){ref-type="ref"}) (Figure [2a](#acel13127-fig-0002){ref-type="fig"}). Additionally, the direction and the magnitude of change in a set of 30 CpG sites correlated strongly with the age‐predicting set of CpGs that are part of the epigenetic clock (Horvath, [2013](#acel13127-bib-0022){ref-type="ref"}) (Figure [2b](#acel13127-fig-0002){ref-type="fig"}). Interestingly, only a small number of the differentially expressed genes had differentially methylated CpG sites (Figure [2c](#acel13127-fig-0002){ref-type="fig"}). These sites were located mainly in gene bodies, and accordingly, the gene expression and the associated DMPs did not correlate; rather, both were decreased in monocytes from older individuals.

![DNA methylation analysis of monocytes extracted from young and old individuals. (a) Comparison of top 10 hypomethylated (first two rows) and top 10 hypermethylated (last two rows) CpG positions in monocytes between age groups. (b) Correlation between DMPs and epigenetic clock CpGs described in Horvath, [2013](#acel13127-bib-0022){ref-type="ref"}. The labels show the nearest genes. (c) Correlation between DMPs and nearest differentially expressed genes. (d) The 3.2 Mb MHC I region depicting genes and DMPs. The lower panel shows the comparison of DNA methylation level of individual CpG sites in monocytes between age groups (sample sizes: 93 young and 91 old individuals). Monocytes were isolated from fresh samples and the cell pellets frozen until DNA extraction. Asterisks show FDR‐adjusted *p*‐value ranges: \**p* \< .05; \*\**p* \< .01; \*\*\**p* \< .001 (moderated *t* test in (a) and (d)). The *r* in (b) and (c) shows the Pearson\'s correlation coefficient](ACEL-19-e13127-g002){#acel13127-fig-0002}

We detected a consistent hypomethylation of CpG sites at MHC class I loci in samples from older individuals (Figure [2d](#acel13127-fig-0002){ref-type="fig"}). The majority of the DMPs within the HLA region were located within gene bodies, including the hypomethylated cg04983903 site within the first intron of the *HLA‐J* pseudogene, which was the only MHC I locus that displayed age‐related differential expression (Figure [1b](#acel13127-fig-0001){ref-type="fig"}). In addition, several sites were hypomethylated within the antigen peptide transporter 2 (TAP2) gene region.

2.3. Age affects phosphatidylcholine content in monocytes {#acel13127-sec-0005}
---------------------------------------------------------

The downregulation of the *PLA2G4B* gene encoding cPLA~2~‐β raised the possibility that PCs which serve as a major input of the arachidonic acid metabolism pathway could have altered concentrations in the monocytes of old individuals. To test this hypothesis, we performed a targeted screening of 188 metabolites with the Biocrates AbsoluteIDQ p180 kit comparing monocyte cell extracts from young adults (average age 33.1 years, standard deviation 3.1) to samples from old individuals (average age 78.3 years, standard deviation 7.7). As lipid‐lowering medication may affect phosphatidylcholine levels, we excluded individuals who had statin treatment from our analysis (the treatment decreased the number and statistical significance of age‐affected phosphatidylcholine (PC) species, Figure [S1](#acel13127-sup-0001){ref-type="supplementary-material"}a). Overall, we were able to reliably detect 77 metabolites, including 56 PCs (Table [S6](#acel13127-sup-0007){ref-type="supplementary-material"}). The statistical comparison of the age groups provided evidence that five PC species, collectively representing 41 potential isomeric molecules, had a significantly higher concentration in cells extracted from older individuals (Figure [3a](#acel13127-fig-0003){ref-type="fig"}).

![Aging affects phosphatidylcholine content of monocytes. (a) Phosphatidylcholine species that display age‐related differences in their concentration. (b) Difference in phosphatidylcholine content in THP‐1 cells after phospholipase A2 inhibition with PACOCF~3~. One‐tailed *t* test: \**p* \< .05. (c) The relative expression of genes *PLA2G4B* and *ALOX15B* in THP‐1 cells after phospholipase A2 inhibition with PACOCF~3~. The sample size was 14 young and 19 old individuals in (a) and 7 independent cell cultures in (b,c). Monocytes were isolated from fresh samples and stored frozen until the lipid content was analyzed. Asterisks show the FDR‐adjusted *p*‐value range \**p* \< .05 (ANOVA)](ACEL-19-e13127-g003){#acel13127-fig-0003}

To determine whether the concentration of PCs depends on the availability of phospholipase A2 activity, we inhibited PLA~2~ enzymes with the small‐molecule inhibitor PACOCF3 and measured the overall PC levels in the monocytic cell line THP‐1. We found that the inhibition of PLA~2~ enzymes significantly increased the concentration of PCs in the THP‐1 cells (Figure [3b](#acel13127-fig-0003){ref-type="fig"}). We also noted that the mRNA levels of *PLA2G4B* or *ALOX15B* genes in THP‐1 cells did not significantly change after PLA~2~ inhibition (Figure [3c](#acel13127-fig-0003){ref-type="fig"}). We conclude that the PC concentrations are affected by the availability of phospholipase A2 activity in monocytes.

2.4. Increased glucose uptake and oxidative stress are age‐dependent {#acel13127-sec-0006}
--------------------------------------------------------------------

The differentially expressed genes in young and old CD14^+^ monocytes prompted us to investigate more deeply the cellular functions related to these gene sets. We used fluorescence emitting substrates and labeled antibodies against key markers of cellular stress and metabolic state that are known to be associated with inflammatory processes, such as phosphorylated STAT3, phosphorylated histone H2AX (γH2AX), phosphorylated p38, and phosphorylated ribosomal protein S6 (Arthur & Ley, [2013](#acel13127-bib-0003){ref-type="ref"}; Bromberg & Darnell, [2000](#acel13127-bib-0007){ref-type="ref"}; Jastrzebski, Hannan, Tchoubrieva, Hannan, & Pearson, [2007](#acel13127-bib-0028){ref-type="ref"}; Rogakou, Pilch, Orr, Ivanova, & Bonner, [1998](#acel13127-bib-0048){ref-type="ref"}). Additionally, we used the glucose analog 2‐NBDG and CM‐H~2~DCFDA to estimate the uptake of glucose and the presence of ROS in monocytes, respectively (Eruslanov & Kusmartsev, [2010](#acel13127-bib-0014){ref-type="ref"}; Yamada, Saito, Matsuoka, & Inagaki, [2007](#acel13127-bib-0066){ref-type="ref"}). Experiments with steady‐state monocytes were complemented with LPS‐treated cells to monitor the age‐related responses to the immunological challenge. The flow cytometric analyses were performed with monocytes extracted from young adults (average age 29.6 years, standard deviation 3.7) and from old individuals (average age 79.4 years, standard deviation 6.3). All analyses excluded older individuals who were using lipid‐lowering medication, although the treatment did not affect the outcome (compare Figures [4](#acel13127-fig-0004){ref-type="fig"} and [S1](#acel13127-sup-0001){ref-type="supplementary-material"}b--g).

![Screening of markers of cellular physiology and stress. Age‐related differences of mock‐ and LPS‐treated monocytes in (a) the inflammation marker p‐STAT3, (b) oxidative stress indicator CM‐H~2~DCFDA, (c) the double‐stranded DNA break marker γH2AX, (d) the glucose uptake indicator 2‐NBDG, (e) the mTOR pathway activity marker p‐S6, and (f) the general cellular stress marker p‐p38. Asterisks show the *p*‐value ranges: \**p* \< .05; \*\**p* \< .01; \*\*\**p* \< .001 (ANOVA)](ACEL-19-e13127-g004){#acel13127-fig-0004}

In agreement with the overall low‐grade inflammation and published research (Shen‐Orr et al., [2016](#acel13127-bib-0052){ref-type="ref"}), the monocytes sorted from older individuals showed significantly higher baseline levels of the inflammation marker p‐STAT3 than those of younger individuals (Figure [4a](#acel13127-fig-0004){ref-type="fig"}). STAT3 is phosphorylated downstream of several cytokines including IL‐6 that is one of the mediators upregulated during inflamm‐aging (Wikby et al., [2006](#acel13127-bib-0063){ref-type="ref"}). LPS treatment was able to augment the p‐STAT3 signal in cells from both age groups albeit with slightly lower dynamics in aged individuals (Table [S7](#acel13127-sup-0008){ref-type="supplementary-material"}). Aging at the cellular level also features a higher concentration of ROS within cells, which has been associated with DNA damage (Davalli, Mitic, Caporali, Lauriola, & D\'Arca, [2016](#acel13127-bib-0013){ref-type="ref"}). On average, we found twofold higher ROS production in unstimulated monocytes in old versus young individuals (Figure [4b](#acel13127-fig-0004){ref-type="fig"}). Furthermore, the percentage of monocytes displaying the histone γH2AX signal, a marker of DNA double‐stranded breaks, was increased about 1.5 times among older subjects (Figure [4c](#acel13127-fig-0004){ref-type="fig"}). Finally, LPS treatment resulted in efficient oxidative burst and highly elevated levels of γH2AX signals in the monocytes of both younger and older persons (Table [S7](#acel13127-sup-0008){ref-type="supplementary-material"}).

Interestingly, we found that monocytes from older individuals were more ready to take up the glucose analog 2‐NBDG (Figure [4d](#acel13127-fig-0004){ref-type="fig"}). Moreover, treatment with LPS did not affect the uptake in cells from older donors, whereas monocytes from young individuals reacted to LPS by significantly increasing the 2‐NBDG uptake (Table [S7](#acel13127-sup-0008){ref-type="supplementary-material"}). The tendency to take up more 2‐NBDG was evident both in classical (CD16^−^) and nonclassical (CD16^+^) monocytes, although the small sample size limited the statistical evaluation (Figure [S2](#acel13127-sup-0001){ref-type="supplementary-material"}a). To further assess the metabolic state of monocytes in the different age groups, we also tested the activation of the mammalian target of rapamycin (mTOR) signaling cascade, which converges many metabolic and other cellular signals and promotes anabolic processes, thereby leading to cell proliferation and growth (Loewith & Hall, [2011](#acel13127-bib-0035){ref-type="ref"}; Wullschleger, Loewith, & Hall, [2006](#acel13127-bib-0064){ref-type="ref"}). We measured the phosphorylation of the ribosomal S6 protein, which is the target of ribosomal protein S6 kinase beta‐1 (p70‐S6K1), a downstream target of the mTOR pathway (Magnuson, Ekim, & Fingar, [2012](#acel13127-bib-0038){ref-type="ref"}). We did not find significant differences in the level of S6 phosphorylation between the age groups with or without LPS treatment (Figure [4e](#acel13127-fig-0004){ref-type="fig"}). However, LPS treatment alone resulted in a dramatic 8‐ to 10‐fold increase of the phosphorylated S6 (pS6) in both age groups indicating that the cells were equally responsive to external stimuli (Table [S7](#acel13127-sup-0008){ref-type="supplementary-material"}). However, the subtle in vivo differences in pS6 at the cell population level are not easily detectable, as the nutrients in the culture medium tend to activate mTOR (Sengupta, Peterson, & Sabatini, [2010](#acel13127-bib-0051){ref-type="ref"}).

We also tested whether monocytes from older subjects display general cellular stress response by measuring the phosphorylated form of p38 mitogen‐activated protein kinase (MAPK), which is activated by cytokines and itself regulates the expression of many inflammatory mediators (Arthur & Ley, [2013](#acel13127-bib-0003){ref-type="ref"}). Interestingly, our results show that the phosphorylation of p38 in monocytes is not age‐dependent (Figure [4f](#acel13127-fig-0004){ref-type="fig"}); however, the stress marker was strongly activated when the cells were treated with LPS irrespective of age (Table [\[Link\]](#acel13127-sup-0001){ref-type="supplementary-material"}, [\[Link\]](#acel13127-sup-0008){ref-type="supplementary-material"}).

2.5. Monocytes from older subjects contain more mitochondria albeit with lower functional capacity {#acel13127-sec-0007}
--------------------------------------------------------------------------------------------------

Published data have shown that the cellular respiratory capacity steadily declines with age, which is a consequence of dysfunctional mitochondria (Bratic & Larsson, [2013](#acel13127-bib-0006){ref-type="ref"}). The higher concentration of ROS in monocytes from old individuals (Figure [4b](#acel13127-fig-0004){ref-type="fig"}) (Jacinto et al., [2018](#acel13127-bib-0026){ref-type="ref"}), as well as the downregulated expression of OXPHOS‐related genes (Figure [1a](#acel13127-fig-0001){ref-type="fig"}), prompted us to test the properties of mitochondria in younger and older subjects. We measured the total mitochondrial mass by the fluorescence signal of MTG and estimated the mitochondrial membrane potential by analyzing the mitochondrial uptake of the membrane potential‐sensitive dye TMR. We noticed a trend for increased mitochondrial mass but lower mitochondrial membrane potential in monocytes from aged persons in both tested conditions (Figure [5a](#acel13127-fig-0005){ref-type="fig"},[b](#acel13127-fig-0005){ref-type="fig"} and Table [\[Link\]](#acel13127-sup-0001){ref-type="supplementary-material"}, [\[Link\]](#acel13127-sup-0008){ref-type="supplementary-material"}). Importantly, the cell‐wise ratios of the dyes revealed significantly lower membrane potential per mitochondrion and thus impaired mitochondrial health in aged monocytes (Figure [5c](#acel13127-fig-0005){ref-type="fig"}). Interestingly, the mitochondrial mass differences were clearly detected in the nonclassical (CD16^+^) monocytes (Figure [S2](#acel13127-sup-0001){ref-type="supplementary-material"}b, Table [\[Link\]](#acel13127-sup-0001){ref-type="supplementary-material"}, [\[Link\]](#acel13127-sup-0009){ref-type="supplementary-material"}). However, the mitochondrial membrane potential and its ratio to mitochondrial mass were decreased in both cell types of old individuals (Figure [S2](#acel13127-sup-0001){ref-type="supplementary-material"}c--d, Table [\[Link\]](#acel13127-sup-0001){ref-type="supplementary-material"}, [\[Link\]](#acel13127-sup-0009){ref-type="supplementary-material"}).

![The decline of cellular respiration of monocytes during aging. Age‐related differences of mock‐ and LPS‐treated monocytes in (a) the overall amount of mitochondria by MitoTracker Green (MTG) staining, (b) the amount of functional mitochondria by tetramethylrhodamine (TMR) staining, and (c) the ratio of functional to total mitochondria. (d) Analysis of the cellular respiration. Oly---Oligomycin; FCCP---p‐trifluoromethoxyphenylhydrazone; Rot + AntA---Rotenone and Antimycin A; SRC---spare respiratory capacity. (e) Comparison of spare respiratory capacity of monocytes between age groups. The sample sizes were 9 young and 16 old individuals for the experiments in (a--c) and 9 young and 9 old individuals in (d,e). The experiments were performed with fresh cells. Asterisks show the *p*‐value ranges: \**p* \< .05; \*\**p* \< .01; \*\*\**p* \< .001 (ANOVA)](ACEL-19-e13127-g005){#acel13127-fig-0005}

To complement the findings on mitochondrial properties, we assayed the oxygen consumption rate (OCR) of monocytes extracted from both younger (average age 29.6 years, standard deviation 3.7) and older individuals (average age 82.3 years, standard deviation 4.7). We determined the basal and maximal respiration of the cells by chemically inhibiting or modifying the different electron transfer complexes in the mitochondrial membrane (Figure [5d](#acel13127-fig-0005){ref-type="fig"}). Based on the measurements, we calculated the spare respiratory capacity (SRC) by subtracting the basal OCR from the maximal OCR and found a significantly lower SRC in cells from older individuals (Figure [5e](#acel13127-fig-0005){ref-type="fig"}).

3. DISCUSSION {#acel13127-sec-0008}
=============

In this study, we compared the genome‐wide gene expression and DNA methylation patterns of CD14^+^ monocytes extracted from young and old individuals and complemented these findings with thorough investigations on age‐related changes of metabolite concentrations and key markers of cellular physiology. Although we concentrated our study on the classical CD14^+^ monocyte subpopulation that is most abundant in the circulation, in parallel we derived some additional hints that CD16^+^ monocytes may undergo similar age‐related changes. The differences in mRNA expression lie mainly in genes with role in protein synthesis and mitochondrial respiration cascade and are in line with previous data (Kumar et al., [2013](#acel13127-bib-0030){ref-type="ref"}; Peters et al., [2015](#acel13127-bib-0044){ref-type="ref"}; Reynolds et al., [2015](#acel13127-bib-0046){ref-type="ref"}; van den Akker et al., [2014](#acel13127-bib-0058){ref-type="ref"}; Zahn et al., [2006](#acel13127-bib-0070){ref-type="ref"}).

The negative effects of aging on protein synthesis and energy metabolism are major hallmarks of aging (López‐Otín et al., [2013](#acel13127-bib-0036){ref-type="ref"}). The aging process in many organisms is associated with alterations of the ribosome biogenesis, an overall decline of protein synthesis and the age‐related reduction of rRNA expression (D\'Aquila et al., [2017](#acel13127-bib-0012){ref-type="ref"}), suggesting that both RNA polymerase II‐ and III‐dependent transcription are affected. The ribosomal protein and RNA expression are controlled by the mTOR pathway (Iadevaia, Liu, & Proud, [2014](#acel13127-bib-0023){ref-type="ref"}), although we could not demonstrate the decreased mTOR activity in aged monocytes. The downregulation of electron transport chain components also correlates with age‐related diseases and shorter lifespan (Bratic & Larsson, [2013](#acel13127-bib-0006){ref-type="ref"}). In agreement, we detected lower mitochondrial membrane potential and higher levels of ROS in monocytes from old individuals. ROS could be derived from damaged mitochondria, or due to increased activity of NADPH oxidase caused by inflammatory signals. However, long‐term exposure to ROS can also lead to mitohormesis, which serves as a protective mechanism against mitochondrial oxidants (Yun & Finkel, [2014](#acel13127-bib-0069){ref-type="ref"}). Thus, the elevated level of ROS in monocytes extracted from old subjects may not serve only as a source of cellular stress, but also counteract it. Interestingly, although we found a tendency for increased phospho‐p38 and pS6 in older individuals, in our study these differences did not reach significance level though they have been shown to increase in stress, aging, and senescence (Arthur & Ley, [2013](#acel13127-bib-0003){ref-type="ref"}; Callender et al., [2018](#acel13127-bib-0008){ref-type="ref"}; Vukmanovic‐Stejic et al., [2018](#acel13127-bib-0061){ref-type="ref"}).

Of the specific top‐listed differentially expressed genes, two upregulated genes, *CX3CR1* and *ARID5B*, have been previously associated with atherosclerosis (Landsman et al., [2009](#acel13127-bib-0031){ref-type="ref"}; Liu et al., [2017](#acel13127-bib-0034){ref-type="ref"}). The chemokine receptor CX3CR1 promotes the migration of monocytes and macrophages to sites of atherosclerotic lesions and its expression correlates with age (Landsman et al., [2009](#acel13127-bib-0031){ref-type="ref"}; Metcalf et al., [2017](#acel13127-bib-0039){ref-type="ref"}). ARID5B is a transcription factor known to promote the activation of lipogenesis‐related genes and to affect cell motility (Yamakawa et al., [2008](#acel13127-bib-0067){ref-type="ref"}). Furthermore, Liu et al. ([2017](#acel13127-bib-0034){ref-type="ref"}) describe a strong link between the knock‐down of *ARID5B* mRNA and the decreased expression of atherosclerosis‐promoting factors. Our analysis lends support to the earlier findings and strengthens the notion that these two proteins have atherogenic properties, as age is one of the major risk factors for atherosclerosis.

We also show that age‐related changes in DNA methylation occur at CpG sites that are now considered markers of aging irrespective of the analyzed tissue (Horvath, [2013](#acel13127-bib-0022){ref-type="ref"}). Many of the sites are part of the so‐called epigenetic clock that correlates with the chronological age of a person, but additionally could predict health issues if the correlation is altered (Horvath, [2013](#acel13127-bib-0022){ref-type="ref"}). However, the relationship between the DNA methylation and gene expression is complex and most of the DNA methylation changes do not result in a significant impact on gene expression (van Eijk et al., [2012](#acel13127-bib-0059){ref-type="ref"}; Horvath, [2013](#acel13127-bib-0022){ref-type="ref"}). Unsurprisingly, our study, which used relatively small sample sizes for the analyses, found only a weak correlation between the differentially expressed genes and DNA methylation sites. Reynolds et al., [2014](#acel13127-bib-0047){ref-type="ref"} have shown that a larger sample size permits the detection of subtle correlations between the data sets, but the functional consequences remain to be elucidated.

Interestingly, we found that *PDK4* mRNA was strongly upregulated in CD14^+^ monocytes from old individuals. Inflammatory signals, such as LPS, increase the expression of PDK4 via JNK pathway (Park & Jeoung, [2016](#acel13127-bib-0041){ref-type="ref"}). In turn, increased PDK4 expression inhibits the pyruvate dehydrogenase complex by phosphorylation of its E1α component (PDHE1α), which shifts glucose metabolism from oxidative phosphorylation toward lactate production. To meet enhanced energy demands, many immune cell types upregulate glycolytic ATP production during their activation (O\'Neill, Kishton, & Rathmell, [2016](#acel13127-bib-0040){ref-type="ref"}). Our data suggest similar glycolytic upregulation during inflamm‐aging as the monocytes from older donors displayed higher uptake of the glucose analog 2‐NBDG. It is noteworthy that LPS stimulation enhanced the 2‐NBDG uptake only in monocytes extracted from younger adults. This suggests that the low‐grade inflammation, which is experienced by monocytes from older people, has already set the glucose utilization speed to its upper limit. The decreased expression of genes related to OXPHOS, decreased mitochondrial potential, and reduced SRC indicate that the balance of energy metabolism has tipped with age from OXPHOS toward aerobic glycolysis. This type of metabolic rewiring has been associated with the generation of "trained innate immunity" that potentiates innate responses against pathogens but is possibly also able to aggravate inflammatory pathology (Bekkering et al., [2016](#acel13127-bib-0005){ref-type="ref"}; Cheng et al., [2014](#acel13127-bib-0011){ref-type="ref"}). Monocytes from aged persons have some similarities to "trained" innate cells but also some important differences. The switch to aerobic glycolysis in healthy monocytes and macrophages helps to obtain fast energy supply and to generate metabolites to carry out the immediate protective function of the cells: cytokine production, oxidative burst for microbicidal function, phagocytosis, and antigen presentation for adaptive immunity (O\'Neill et al., [2016](#acel13127-bib-0040){ref-type="ref"}). Data from published and current research indicate that these functions are impaired in monocytes from aged persons that can result from the cellular energy deficit (Albright et al., [2016](#acel13127-bib-0001){ref-type="ref"}; Metcalf et al., [2017](#acel13127-bib-0039){ref-type="ref"}; Pence & Yarbro, [2018](#acel13127-bib-0043){ref-type="ref"}; Shen‐Orr et al., [2016](#acel13127-bib-0052){ref-type="ref"}). The metabolic fitness of monocytes from aged persons seems to be impaired with decreased mitochondrial respiratory reserve and restricted capacity to utilize additional glucose. As a result, the limited energy supply cannot be spared for ribosomal biogenesis, which is one of the most energy‐consuming processes in the cell (MacInnes, [2016](#acel13127-bib-0037){ref-type="ref"}), and for cytokine production, which is also impaired in aged monocytes according to many previous studies (Metcalf et al., [2017](#acel13127-bib-0039){ref-type="ref"}; Pillai et al., [2016](#acel13127-bib-0045){ref-type="ref"}; Sadeghi et al., [1999](#acel13127-bib-0049){ref-type="ref"}).

The top list of downregulated genes featured *PLA2G4B* and *ALOX15B*, which encode enzymes that belong to consecutive steps in the arachidonic acid metabolism pathway. Because *PLA2G4B* encoded cPLA2‐β utilizes PCs, we analyzed the concentration of a panel of metabolites to discover age‐related differences that could be due to the limited availability of the enzyme. Older individuals had a higher concentration of several PC species in monocytes, and experiments with the monocytic THP‐1 cell line further showed that inhibiting the phospholipase A2 activity increased the amount of PCs content in the cells. Although it is not currently possible to decipher the connection between the specific phospholipases and PC species, we believe that our results establish a basis to investigate the age‐dependent changes in phospholipid turnover in monocytes. Moreover, PC content increases during monocyte activation as the secretory machinery expands to meet the cellular needs for increased cytokine secretion (Langston, Shibata, & Horng, [2017](#acel13127-bib-0032){ref-type="ref"}), which in aging may represent the senescence‐associated secretory phenotype (Shen‐Orr et al., [2016](#acel13127-bib-0052){ref-type="ref"}). Furthermore, many downstream products of the arachidonic acid metabolism pathway are important inflammatory signaling molecules, such as prostaglandins, thromboxanes, leukotrienes, and hydroxyeicosatetraenoic acids, and it would be important to determine their exact role in the context of aging. Our results indicate that the balance of pro‐ and anti‐inflammatory mediators of the pathway may favor inflammation in aged individuals. Additionally, cell type‐specific analysis of metabolite content would be helpful in determining how the different subsets affect the repertoire of blood plasma metabolites that have been established previously (Yu et al., [2012](#acel13127-bib-0068){ref-type="ref"}).

In summary, we show that CD14^+^ monocytes from older individuals undergo changes in gene expression and DNA methylation changes that reflect the hallmarks of aging. These results are complemented by new insights into changes in phospholipids, and the metabolic and signaling status of monocytes during aging. Considering the central role of monocytes bridging the signals of innate and adaptive immunity, it would be highly valuable to advance our understanding of the metabolic processes that occur in monocytes and to use it to mitigate age‐related conditions.

4. EXPERIMENTAL PROCEDURES {#acel13127-sec-0009}
==========================

All experimental procedures are described in detail in the [Supporting Information](#acel13127-sup-0010){ref-type="supplementary-material"} file.
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